Product NDC: | 17156-524 |
Proprietary Name: | Metastron |
Non Proprietary Name: | Strontium Chloride Sr-89 |
Active Ingredient(s): | 1 mCi/mL & nbsp; Strontium Chloride Sr-89 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17156-524 |
Labeler Name: | Medi-Physics Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020134 |
Marketing Category: | NDA |
Start Marketing Date: | 19930618 |
Package NDC: | 17156-524-01 |
Package Description: | 10 mL in 1 VIAL (17156-524-01) |
NDC Code | 17156-524-01 |
Proprietary Name | Metastron |
Package Description | 10 mL in 1 VIAL (17156-524-01) |
Product NDC | 17156-524 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Strontium Chloride Sr-89 |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19930618 |
Marketing Category Name | NDA |
Labeler Name | Medi-Physics Inc. |
Substance Name | STRONTIUM CHLORIDE SR-89 |
Strength Number | 1 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] |